| |
|
|
|
Matinas Biopharma Hl
|
|
1.36 +0.04 (+3.03%) |
8/18/2017 3:59pm |
|
Open: |
1.28 |
Pre close: |
1.32 |
Target:
|
1.75
|
|
High: |
1.44 |
Low: |
1.25 |
Resistance:
|
1.50
1.75
|
|
Volume: |
303,820 |
Market Cap: |
125.08M |
Support:
|
1.20
1.01
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.38
 |
MACD |
MACD(12,26):
|
-0.07 |
|
MA(20): |
1.27 |
Signal(12,26,9): |
-0.12 |
|
MA(100): |
2.24  |
Stochastic Oscillator |
%K(14,3):
|
73.19 |
|
MA(250): |
2.06 |
%D(3): |
78.26 |
|
Average Volume(K) |
3-Month: |
59984
|
52-Week |
High:
|
3.99 |
|
10-Days: |
18824 |
Low: |
0.67 |
|
RSI |
RSI(14):
|
47.13 |
Change(%): |
83.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.480 |
Return on Equity (ttm) |
-85.4 |
Shares Out. (M) |
91.40 |
|
EPS Est. Current Year |
-0.260 |
Return on Assets (ttm) |
-45.6 |
Shares Float (M) |
68.93 |
|
EPS Est. Next Year |
-0.240 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.050 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
0.00 |
|
Forward EPS |
-0.250 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
4760 |
|
Book Value (p.s.) |
0.140 |
EBITDA (p.s.) |
-0.114 |
P/E |
-2.83 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
9.71 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-7.61 |
P/S |
0.00 |
|
Operating Margin |
-70190.86 |
Levered Free Cash Flow
(M) |
-4.16 |
P/CF |
-16.33 |
|
|
|
|
 |
|
|
|
